Rheologics to become KKS:
This article was originally published in Clinica
Developer of devices for the diagnosis and treatment of vascular disease Rheologics Technologies is to change its name to KKS Venture Management, in line with the company's shift towards diversifying in order to improve its cash flow. The Exton, Pennsylvania-based company will continue its research into cardiovascular disease, but has chosen to transition into revenue-generating products, and will function as a venture holding company in a bid to preserve value for its shareholders. KKS' new trading symbol is "KKSV".